4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-23-011545
Director bought 2,750 shares at $3.73 ($10,258)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Truitt Joseph Director | 2023-05-17 | Purchase | +2,750 | $3.73 | $10,258 | 2,750 | D: show line 1 in the form |
| Open-market purchases · 2,750 sh · avg $3.73 · $10,258 | |||||||
Loading xslF345X04/form4.xml…